Skip to content

The association of genetic variants and outcome of in vitro fertilization cycles

The research of gene polymorphisms of hormonal signals genes in women entering in vitro fertilization program

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN12768989
Enrollment
2000
Registered
2016-01-07
Start date
2013-12-23
Completion date
Unknown
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

In vitro fertilization (IVF) Pregnancy and Childbirth In vitro fertilization (IVF)

Interventions

All participating patients received controlled ovarian hyperstimulation protocols and oocyte retrieval procedures to get a number of oocytes. These oocytes were processed with in vitro fertilization/i

Sponsors

Chung Shan Medical Unviersity Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Age 20 to 45 years old 2. Infertile patients who need IVF treatment 3. Qualified for IVF treatment

Exclusion criteria

Exclusion criteria: 1. Part of the oocyte donation program 2. Part of the sperm donation program

Design outcomes

Primary

MeasureTime frame
Oocyte number, measured using microscopy observation at the time of oocyte retrieval

Secondary

MeasureTime frame
1. Embryo quality is measured using microscopy observation for the number of blastomere, fragmentation degree at day 3 or day 5 after oocyte retrieval 2. Pregnancy rate is measured using serum beta-HCG test and ultrasound examination at 18 days and 32 days after oocyte retrieval, respectively 3. Implantation rate is measured using the total sac numbers divided by total transfer embryo number at the time of ultrasound examination

Countries

Taiwan

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026